Sotera Health stock kpis
Want to see SHC full AI Analyst Report?
Capital Expenditure by Segment
Sotera Health reported capital expenditure by segment of $52.84M in Q3 2026, up 13.7% from Q2 2026 and up 46.1% year over year. The highest value was $71.74M in Q4 2022.
Shows how Sotera allocates capital spending across its business units such as sterilization, lab testing, and support services. High capex in a segment signals capacity expansion and growth investment; low or steady capex may indicate mature operations or underinvestment. The capex mix affects future revenue potential, maintenance obligations, free cash flow, and whether spending is driven by regulatory compliance or efficiency projects that could improve margins.
Sterigenics is the clear capital focus — ongoing, H2‑weighted investments to expand capacity and upgrade EO systems are driving most of Sotera’s capex, while Nordion and Nelson Labs show smaller, lumpy spikes tied to Cobalt‑60 harvest timing and clean‑room projects. Management’s raised 2026 guidance and $200–$225M capex plan confirm these are growth investments, but expect higher depreciation and near‑term margin pressure; the company points to lower interest costs and improving leverage (3.0x trending toward 2–3x) to mitigate financing risk. Nordion remains timing‑sensitive, so shipment cadence can create revenue/capex volatility.
SHC Capital Expenditure by Segment
| Period | Sterigenics | Nordion | Nelson Labs | Total |
|---|---|---|---|---|
| Q3 2026Sep 30, 2026 | $44.58M | $4.83M | $3.42M | $52.84M |
| Q2 2026Jun 30, 2026 | $39.52M | $3.37M | $3.56M | $46.45M |
| Q1 2026Mar 31, 2026 | $37.89M | $4.29M | $3.98M | $46.17M |
| Q4 2025Dec 31, 2025 | $34.51M | $6.60M | $9.59M | $50.70M |
| Q3 2025Sep 30, 2025 | $28.37M | $5.18M | $2.63M | $36.17M |
| Q2 2025Jun 30, 2025 | $20.11M | $7.67M | $3.46M | $31.23M |
| Q1 2025Mar 31, 2025 | $16.39M | $2.39M | $1.13M | $19.92M |
| Q4 2024Dec 31, 2024 | $47.28M | $11.52M | $7.07M | $65.87M |
| Q3 2024Sep 30, 2024 | $30.18M | $3.95M | $2.27M | $36.39M |
| Q2 2024Jun 30, 2024 | $31.52M | $8.73M | $1.67M | $41.92M |
| Q1 2024Mar 31, 2024 | $22.27M | $10.74M | $1.88M | $34.89M |
| Q4 2023Dec 31, 2023 | $47.60M | $14.48M | $2.75M | $64.83M |
| Q3 2023Sep 30, 2023 | $41.71M | $7.59M | $2.71M | $52.02M |
| Q2 2023Jun 30, 2023 | $42.85M | $5.74M | $4.55M | $53.13M |
| Q1 2023Mar 31, 2023 | $30.88M | $10.54M | $3.58M | $45.00M |
| Q4 2022Dec 31, 2022 | $53.58M | $14.53M | $3.62M | $71.74M |
| Q3 2022Sep 30, 2022 | $29.84M | $3.65M | $2.60M | $36.10M |
| Q2 2022Jun 30, 2022 | $35.38M | $1.30M | $2.32M | $39.00M |
| Q1 2022Mar 31, 2022 | $25.22M | $7.09M | $3.23M | $35.55M |
| Q4 2021Dec 31, 2021 | $25.20M | $13.76M | $2.30M | $41.26M |
| Q3 2021Sep 30, 2021 | $12.70M | $1.16M | $2.25M | $16.11M |
| Q2 2021Jun 30, 2021 | $16.34M | $5.89M | $1.62M | $23.85M |
| Q1 2021Mar 31, 2021 | $19.51M | $489.00K | $939.00K | $20.94M |

